[HTML][HTML] Cadherin signaling in cancer and autoimmune diseases
Cadherins mediate cell–cell adhesion through a dynamic process that is strongly dependent
on the cellular context and signaling. Cadherin regulation reflects the interplay between …
on the cellular context and signaling. Cadherin regulation reflects the interplay between …
Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy
Dormancy occurs when cells preserve viability but stop proliferating, which is considered an
important cause of tumor relapse, which may occur many years after clinical remission …
important cause of tumor relapse, which may occur many years after clinical remission …
Multifunctional magnetic nanoclusters can induce immunogenic cell death and suppress tumor recurrence and metastasis
Metastasis is the predominant cause of cancer deaths due to solid organ malignancies;
however, anticancer drugs are not effective in treating metastatic cancer. Here we report a …
however, anticancer drugs are not effective in treating metastatic cancer. Here we report a …
[HTML][HTML] Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling
HC Wang, LY Haung, CJ Wang, YJ Chao… - Journal of biomedical …, 2022 - Springer
Background Sorafenib (SOR) is the first line treatment for advanced hepatocellular
carcinoma (HCC), but resistance develops frequently. Tumor-associated macrophages …
carcinoma (HCC), but resistance develops frequently. Tumor-associated macrophages …
[HTML][HTML] Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape
R Ganesan, SS Bhasin, M Bakhtiary, U Krishnan… - PLoS …, 2023 - journals.plos.org
A major cause of cancer recurrence following chemotherapy is cancer dormancy escape.
Taxane-based chemotherapy is standard of care in breast cancer treatment aimed at killing …
Taxane-based chemotherapy is standard of care in breast cancer treatment aimed at killing …
[HTML][HTML] Quiescent cancer cells—a potential therapeutic target to overcome tumor resistance and relapse
E Lindell, L Zhong, X Zhang - International Journal of Molecular Sciences, 2023 - mdpi.com
Quiescent cancer cells (QCCs) are nonproliferating cells arrested in the G0 phase,
characterized by ki67low and p27high. QCCs avoid most chemotherapies, and some …
characterized by ki67low and p27high. QCCs avoid most chemotherapies, and some …
Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence
Tumor recurrence is a paradoxical function of a machinery, whereby a small proportion of
the cancer cell population enters a resistant, dormant state, persists long-term in this …
the cancer cell population enters a resistant, dormant state, persists long-term in this …
Perioperative escape from dormancy of spontaneous micro-metastases: A role for malignant secretion of IL-6, IL-8, and VEGF, through adrenergic and prostaglandin …
R Haldar, LS Berger, A Radin, A Eckerling… - Brain, Behavior, and …, 2023 - Elsevier
We recently showed that a minimally-invasive removal of MDA-MB-231 HM primary tumors
(PTs) and elimination of their secreted factors (including IL-6, IL-8, VEGF, EGF, PDGF-aa …
(PTs) and elimination of their secreted factors (including IL-6, IL-8, VEGF, EGF, PDGF-aa …
[HTML][HTML] Clinical and biological aspects of disseminated tumor cells and dormancy in breast cancer
Progress in detection and treatment have drastically improved survival for early breast
cancer patients. However, distant recurrence causes high mortality and is typically …
cancer patients. However, distant recurrence causes high mortality and is typically …
[HTML][HTML] Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
D Ajmeera, R Ajumeera - Genes & Diseases, 2024 - Elsevier
Chemotherapy is an effortless and frequently used approach in cancer therapy. However, in
most cases, it can only prolong life expectancy and does not guarantee a complete cure …
most cases, it can only prolong life expectancy and does not guarantee a complete cure …